As others demonstrated that illness severity is not strictly related to viral load and, by consequence, to contagiousness, we excluded patients with severe or moderate symptoms or COVID-19-confirmed cases from our study, basing this choice on the will to evaluate the performance of the Ag-RDT on “first entries” in a screening/surveillance setting. This evidence concerns the gene RENBP and COVID-19.